Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia
Clinical trial NCT03630042 · COMPLETED
Trial details
- NCT number
- NCT03630042
- Sponsor
- University College, London
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2021-09-21
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.